UA96736C2 - Ингибиторы pi3k для лечения эндометриоза - Google Patents

Ингибиторы pi3k для лечения эндометриоза

Info

Publication number
UA96736C2
UA96736C2 UAA200801628A UAA200801628A UA96736C2 UA 96736 C2 UA96736 C2 UA 96736C2 UA A200801628 A UAA200801628 A UA A200801628A UA A200801628 A UAA200801628 A UA A200801628A UA 96736 C2 UA96736 C2 UA 96736C2
Authority
UA
Ukraine
Prior art keywords
endometriosis
treatment
pi3k inhibitors
pi3k inhibitor
relates
Prior art date
Application number
UAA200801628A
Other languages
English (en)
Ukrainian (uk)
Inventor
Стивен С. Палмер
Селварадж Натараджа
Original Assignee
Мерк Сероно Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Сероно Са filed Critical Мерк Сероно Са
Publication of UA96736C2 publication Critical patent/UA96736C2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Это изобретение касается способа лечения и/или предупреждения эндометриоза, который включает введение ингибитора PI3K. Ингибитор PI3K может также быть введен в комбинации с гормональным супрессором. Изобретение дополнительно касается лечения связанного с эндометриозом бесплодия.
UAA200801628A 2005-09-07 2006-08-28 Ингибиторы pi3k для лечения эндометриоза UA96736C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71464405P 2005-09-07 2005-09-07

Publications (1)

Publication Number Publication Date
UA96736C2 true UA96736C2 (ru) 2011-12-12

Family

ID=40079569

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200801628A UA96736C2 (ru) 2005-09-07 2006-08-28 Ингибиторы pi3k для лечения эндометриоза

Country Status (4)

Country Link
JP (1) JP2009507072A (ru)
CN (1) CN101300047A (ru)
UA (1) UA96736C2 (ru)
ZA (1) ZA200802080B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009098021A1 (en) * 2008-02-04 2009-08-13 Cellzome Ag Selectivity profiling of pi3k interacting molecules against multiple targets
PL2794600T3 (pl) * 2011-12-22 2018-06-29 Novartis Ag Pochodne 2,3-dihydro-benzo[1,4]oksazyny i powiązane związki jako inhibitory kinazy fosfoinozytydu-3 (PI3K) do leczenia np. reumatoidalnego zapalenia stawów
TW201422625A (zh) * 2012-11-26 2014-06-16 Novartis Ag 二氫－吡啶并－□衍生物之固體形式
CN108570043A (zh) * 2018-06-20 2018-09-25 王延娇 一种化合物及其作为选择性pi3k抑制剂在***中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2489779A1 (en) * 2002-07-10 2004-01-22 Applied Research Systems Ars Holding N.V. Use of compounds for increasing spermatozoa motility
RS115904A (en) * 2002-07-10 2006-12-15 Applied Research Systems Ars Holding N.V. Azolidinone-vinyl fused benzene derivatives
CA2506320A1 (en) * 2002-11-21 2004-06-10 Genentech, Inc. Therapy of non-malignant diseases or disorders with anti-erbb2 antibodies
WO2005011686A1 (en) * 2003-07-28 2005-02-10 Applied Research Systems Ars Holding N.V. 2-imino-4-(thio) oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors

Also Published As

Publication number Publication date
ZA200802080B (en) 2009-09-30
JP2009507072A (ja) 2009-02-19
CN101300047A (zh) 2008-11-05

Similar Documents

Publication Publication Date Title
EA200800755A1 (ru) Ikk ингибиторы, предназначенные для лечения эндометриоза
WO2007030360A3 (en) P13k inhibitors for the treatment of endometriosis
MY150697A (en) Methods of treating cancer using pyridopyrimdinone inhibitors of p13k alpha
MX2008011633A (es) Aminoquinolonas como inhibidores de gsk-3.
TN2010000209A1 (en) Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents
MX366119B (es) Uso de un agente inhibidor de masp-2 para el tratamiento de condiciones renales mediadas por complemento dependiente de la masp-2.
MY150797A (en) Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer
MX2010012270A (es) Inhibidores de dpp-iv para uso en el tratamiento de enfermedad hepatica grasa no alcoholica.
JO2886B1 (en) Useful compounds in the inhibition of CHK1
MX348941B (es) Medios y metodos para trata y/o prevenir el cancer dependiente del ligando natural de receptor de aril-hidrocarburo.
HK1162502A1 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3
TN2012000205A1 (en) Method and compositions for treating solid tumors and other malignancies
WO2006081371A3 (en) Combination therapy with triterpenoid compounds and proteasome inhibitors
UA96736C2 (ru) Ингибиторы pi3k для лечения эндометриоза
ZA200710497B (en) Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders
WO2007149543A3 (en) Scar treatment using protein phosphatase inhibitors
WO2008063853A3 (en) Cancer treatment method
TW200603792A (en) Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors
WO2007136615A3 (en) Combination cancer therapy
SG165343A1 (en) Jnk inhibitors for the treatment of endometriosis
TW200642688A (en) New use of PDE7 inhibitors
DK2041181T3 (da) Specifikke proteaseinhibitorer og deres anvendelse i cancerterapi
WO2006042277A3 (en) Extended release compositions of proton pump inhibitors
UA89242C2 (ru) Способ лечения эндометриоза с применением ингибитора jnk, которым является производное бензотиазола
NZ617989A (en) Use of pnp inhibitors such as forodesine in combination with alkylating agents for treating hematologic cancers